A Study to Evaluate the PK Similarity of AK104 in Healthy Chinese Male Participations
This study is to evaluate the pharmacokinetic (PK) similarity of AK104 (an anti-PD-1/CTLA-4 bispecific antibody) from the proposed new manufacturing site and the approved original site in healthy male participants.
Able to provide signed informed consent prior to the trial and fully understand... [+4]
Have a history of diseases of the digestive, respiratory, cardiovascular, endocr... [+24]